Pragmatic Pharmacological and Economic Analysis of Insulin Glargin Use in Type 2 Diabetes Mellitus in Ukraine
The article deals with the question of insulin therapy in type 2 diabetic patients. There are demonstrated the results of pragmatic trial of clinical and economic reasonability of transferring of the type 2 diabetic patients from NPH insulin treatment for the therapy with insulin glargin in routine...
Main Authors: | N.V. Bezdetko, O.N. Kirichenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2014-04-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | http://iej.zaslavsky.com.ua/article/view/76663 |
Similar Items
-
Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2
by: I. N. Dyakov, et al.
Published: (2020-05-01) -
Pharmacoeconomic Analysis of Prolonged Insulin Analogues Usage in Type 2 Diabetes Mellitus under the Conditions of Ukrainian Pharmaceutical Market
by: N.V. Bezdetko, et al.
Published: (2014-10-01) -
Economic evaluation of the fixed combination of insulin glargine and lixisenatide in Diabetes Mellitus type 2
by: S. V. Nedogoda, et al.
Published: (2020-01-01) -
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
by: Lau IT, et al.
Published: (2017-06-01) -
Intensive Insulin Titration with Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients in Turkey: LANTIT Study
by: Ercan Tuncel, et al.
Published: (2015-09-01)